Early Detection
415 articles
Annual Report
With Hope On The Horizon Let’s Win has become known as a vital source of information and a go-to resource for pancreatic cancer patients everywhere. Among the highlights of the past year: With new methods of early detection on the horizon, we feel both hope for the future and more urgency than ever to raise […]
Barbara J. Kenner, Ph.D.
Barbara Kenner established Kenner Family Research Fund (KFRF) in memory of her husband Peter, who died shortly after he was diagnosed with pancreatic neuroendocrine cancer. The purpose of KFRF is to facilitate the development of an early detection methodology for pancreatic cancer in order to improve survival. Dr. Kenner is a founding partner of Neuropsychological […]
The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.
More Research Needed for Pancreatic Cancer Immunotherapy
Dr. Luis Diaz provides a status check for immunotherapy treatments for pancreatic cancer, including an explanation of different types.
AACR Virtual Special Conference on Pancreatic Cancer: Day Two Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day Two of the AACR Virtual Special Conference on Pancreatic Cancer.
PancChat Featured in a Journal Article
PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.
A Fighting Spirit
Resilience best describes Dr. Errol D. Toulon, Jr., a long-term survivor of lymphoma, pancreatic cancer, and a heart emergency.
Blessed to Be Here and Healthy
Jacqueline Sims-Mayes is blessed to be a pancreatic cancer survivor. Her faith helped her through a difficult recovery from Whipple surgery.
New Cancer Stem Cell Pathway Drug May Change Standard of Care
Dr. Tanios Bekaii-Saab is testing a new drug that works on pancreatic cancer stem cells to make chemotherapy more effective.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Studying One Family’s Mutations May Change Pancreatic Cancer Treatment and Prevention
Dr. Sahar Nissim is studying the genetic mutations in one family predisposed to pancreatic cancer, to find new ways to combat the disease.
New Drug Shows Positive Results in Early Trials
A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.
Vigilance in Pursuing Symptoms Leads to Early Diagnosis
Jay Buth was very persistent in pursuing the reason for his symptoms. That led to a diagnosis of early stage pancreatic cancer.
Facing My Biggest Danger: Pancreatic Cancer
After Gary Carmichael finally found the source of his digestive troubles, he had a Whipple procedure to remove his pancreatic cancer.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.